Home/Filings/4/0000950170-25-064122
4//SEC Filing

MCNAMARA KEVIN J 4

Accession 0000950170-25-064122

CIK 0000019584other

Filed

May 5, 8:00 PM ET

Accepted

May 6, 11:59 AM ET

Size

10.2 KB

Accession

0000950170-25-064122

Insider Transaction Report

Form 4
Period: 2025-05-05
MCNAMARA KEVIN J
Directorpresident and CEO
Transactions
  • Exercise/Conversion

    Stock Option (right to buy with tandem tax withholding)

    2025-05-05$471.74/sh10,000$4,717,400207,487 total
    Exercise: $471.74Exp: 2025-10-29Capital Stock (10,000 underlying)
  • Sale

    Capital Stock

    2025-05-05$576.45/sh1,500$864,675101,197 total
  • Exercise/Conversion

    Capital Stock

    2025-05-05$471.74/sh+10,000$4,717,400111,679 total
  • Tax Payment

    Capital Stock

    2025-05-05$574.02/sh8,982$5,155,848102,697 total
Footnotes (3)
  • [F1]Payment of purchase price and tax obligation on stock option exercise.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $573.98 to $579.54. The reporting person undertakes to provide to Chemed Corporation, any security holder of Chemed Corporation, or staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) of this Form 4.
  • [F3]Vesting in three equal annual installments commencing 10/29/2021

Documents

1 file

Issuer

CHEMED CORP

CIK 0000019584

Entity typeother

Related Parties

1
  • filerCIK 0001207137

Filing Metadata

Form type
4
Filed
May 5, 8:00 PM ET
Accepted
May 6, 11:59 AM ET
Size
10.2 KB